Influence of POLG on Radiosensitivity of Nasopharyngeal Carcinoma Cells

Cancer Biotherapy & Radiopharmaceuticals
Ruiqing ChenLurong Zhang

Abstract

There is a high incidence of nasopharyngeal carcinoma (NPC), malignant head and neck tumors, in southern China. Radioresistance is the main cause affecting the efficacy of NPC treatments. The POLG gene particularly plays an important role in radiation-induced damage repair. In this study, the authors established RNAi CNE-1 and CNE-2 knockdown in two NPC cell lines to observe whether this gene affects the radiosensitivity of NPC cells. Four short hairpin RNA (shRNA) expression plasmids targeting POLG gene were constructed and transfected into the NPC cell lines CNE-1 and CNE-2. Screening was performed to evaluate the stable expression of cloned cells, which were named CNE-1/POLG-shRNA1, CNE-1/POLG-shRNA2, CNE-2/POLG-shRNA1, and CNE-2/POLG-shRNA2. The negative controls CNE-1/Neg-shRNA and CNE-2/Neg-shRNA were additionally used. The MTT method, flow cytometry, clone formation analysis, cell migration, and other experimental methods were employed to verify changes in the radiosensitivity of the NPC cells. Fluorescent quantitative PCR and Western blot confirmed the downregulation of the PLOG gene through diminished PLOG messenger RNA and protein levels. Consequently, the authors report the stable knockdown of the POLG gene in an NPC...Continue Reading

References

Sep 15, 1988·International Journal of Cancer. Journal International Du Cancer·R FåhraeusP Busson
Jun 7, 2005·International Journal of Radiation Oncology, Biology, Physics·Shyh-An YehEng-Yen Huang
Aug 21, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Yong LiuYuanzheng Qiu
Aug 1, 2012·Journal of Cancer Research and Clinical Oncology·Bin ZhangXue-Ping Feng
Apr 16, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Guo LiYuanzheng Qiu
Oct 30, 2016·Oncotarget·Linli ZhangGuoqing Hu
Dec 7, 2016·Journal of Experimental & Clinical Cancer Research : CR·Teng HuangXia He
Dec 18, 2016·Psychiatry and Clinical Neurosciences·Takaoki KasaharaTadafumi Kato
Jan 6, 2017·Cancer Cell International·Chao LiuYuanzheng Qiu
Jan 29, 2017·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Paola Da PozzoAntonio Federico
Feb 25, 2017·Molecular Cancer Research : MCR·Kuntal BiswasJames M Larner
Apr 14, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Ruzhen ZhengQinghua Deng
May 6, 2017·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·X QianJ Cai

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry
transfection

Software Mentioned

FlowJo
SPSS

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.